OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Dora Kovacs

1 Projects | 1 Researchers | $125,000 Invested

2002

Massachusetts General Hospital (P)

Dora Kovacs, PhD

Effect of ACAT Inhibition on A-Beta Levels in PS1-APP Transgenic Mice

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed